Anna Spreafico

9.3k citations

229 papers · 3.8k indexed · h-index 31

Impact in

Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- CAR-T cell therapy research
Otorhinolaryngology top 1%
- Head and Neck Cancer Studies

Papers in

Otorhinolaryngology 38
- Head and Neck Cancer Studies 38
Oncology 148
- Cancer Immunotherapy and Biomarkers 65
- Colorectal Cancer Treatments and Studies 37
- CAR-T cell therapy research 25
- Pancreatic and Hepatic Oncology Research 15

Co-authors: Lillian L. Siu Vanesa Gregorc Aaron R. Hansen Philippe L. Bédard Bryan Coburn Marc Oliva Fred R. Hirsch Giovanni Luca Ceresoli
Journals: Journal of Clinical Oncology (59 papers)Annals of Oncology (29 papers)Clinical Cancer Research (7 papers)Radiotherapy and Oncology (7 papers)Cancer (7 papers)
Partner nations: Canada United States Italy

In The Last Decade

Anna Spreafico

210 papers receiving 3.7k citations

Peers

Countries citing papers authored by Anna Spreafico

Since Specialization

Citations

This map shows the geographic impact of Anna Spreafico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Spreafico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Spreafico more than expected).

Fields of papers citing papers by Anna Spreafico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Spreafico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Spreafico. The network helps show where Anna Spreafico may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Spreafico, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Spreafico Line = papers co-authored together Anna Spreafico links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial mBio ·永作崎原, Hae-Sung Yoon, Alya Heirali, Pierre H. H. Schneeberger, Helen Chen, Kyla Cochrane, S. Ryu, Emma Allen‐Vercoe, Lillian L. Siu, Anna Spreafico, Bryan Coburn	2025	0
2	Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors JTO Clinical and Research Reports ·Dwi Nur Syamsiyati, 綾田研三, Hans Katzberg, Vera Bril, Gupta Ab, Warren Mason, Jun-Bock Jang, Aideen E. Ryan, David W. Hogg, Srikala S. Sridhar, Neesha C. Dhani, Anna Spreafico, Lawson Eng, Adrian G. Sacher, Penelope A. Bradbury, Geoffrey Liu, Natasha B. Leighl, Frances A. Shepherd	2024	0
3	Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1) Journal for ImmunoTherapy of Cancer ·Ulka N. Vaishampayan, Jameel Muzaffar, Ira Winer, Ronggen Zhang, Keeyong Kwak, Aman Chauhan, Anna Spreafico, Karl D. Lewis, Débora S. Bruno, Olivier Dumas, David H. McDermott, James Strauss, Quincy S. Chu, Lucy Gilbert, Arvind Chaudhry, Emiliano Calvo, Rita P. Dalal, Valentina Boni, Marc S. Ernstoff, Vamsidhar Velcheti	2024	14
4	Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Final results of the investigator-initiated phase II BEAVER trial. Journal of Clinical Oncology ·April A. N. Rose, J. S. Roskell, C P Dubbelman, 杨佳瑛, A. HAMRING, Meghan Mcguire, Ian King, Tong Zhang, Yano Yuri, Trevor J. Pugh, Marcus O. Butler, Frances A. Shepherd, Philippe L. Bédard, Natasha B. Leighl, Albiruni Ryan Abdul Razak, Aaron R. Hansen, Samuel D. Saibil, Lillian L. Siu, David W. Cescon, Anna Spreafico	2024	2
5	Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers International Journal of Molecular Sciences ·Pavlina Spiliopoulou, Olga Vornicova, Sofia Genta, Anna Spreafico	2023	8
6	1131P Management of metastatic uveal melanoma (MUM) patients on tebentafusp in a real-world setting Annals of Oncology ·Maria Flávia Marques Ribeiro, Jiaming Huang, Elizabeth Koch, Alexandra Feld, Gwynedd Williams, Caio Augustus Diamantino, ALESSANDRA BEATRIZ CARNEIRO GONÇALVES, June-Jeong Lee, Sofia Genta, Pavlina Spiliopoulou, Olga Vornicova, Sara María García Amaya, Elisa Giovannetti, Hatem Krema, Rasika Mange, Anna Spreafico, Marcus O. Butler	2023	3
7	The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies Cancers ·Г Н Тюрикова, Fernando L. B. B. Oliveira, عبدالمالك ضيف, Gwynedd Williams, Xiang Y. Ye, Anna Spreafico, Samuel D. Saibil, A. Sun, Kim Suhk-Chul, Syahrial Mukhtar, Nur Alia Latifa, Philip Wong, Marcus O. Butler	2023	1
8	Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients European Journal of Cancer ·Kirsty Taylor, Jinfeng Zou, Pournima Shah, Marc Oliva, Anna Spreafico, Aaron R. Hansen, Simon S. McDade, Vicky M. Coyle, Mark Lawler, Elena Elimova, Scott V. Bratman, Lillian L. Siu	2023	14
9	Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre Cancers ·董雪, An. S. Kiselev, Jiaming Huang, عبدالمالك ضيف, Gwynedd Williams, Yanran Yuan, ALESSANDRA BEATRIZ CARNEIRO GONÇALVES, C Braekevelt, Ryohei Otani, Anna Spreafico, Chien Yu Yeh, Marcus O. Butler, Samuel D. Saibil	2023	10
10	Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Justin Burgener, Jinfeng Zou, Zhen Zhao, J. P. Argyle, Shu Yi Shen, Shao Hui Huang, Sareh Keshavarzi, Wei Xu, Fei‐Fei Liu, Geoffrey Liu, John Waldron, Ilan Weinreb, Anna Spreafico, Lillian L. Siu, John R. de Almeida, David P. Goldstein, Michael M. Hoffman, Daniel D. De Carvalho, Scott V. Bratman	2021	53
11	Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort Radiotherapy and Oncology ·小西暁子, Eugene Yu, Brian O’Sullivan, Jie Su, Zoe K. Scott-Nevros, Lillian L. Siu, John Waldron, John Kim, Aaron R. Hansen, Andrew Hope, John Cho, Meredith Giuliani, Jolie Ringash, Anna Spreafico, Scott V. Bratman, Ali Hosni, Ezra Hahn, Tong Li, Wei Xu, Shao Hui Huang	2021	25
12	Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials JNCI Journal of the National Cancer Institute ·Zachary Veitch, Daniel Shepshelovich, Andrea Santamaria, Lisa Wang, Albiruni R. Abdul Razak, Anna Spreafico, Philippe L. Bédard, Lillian L. Siu, Lori M. Minasian, Aaron R. Hansen	2021	40
13	The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer Clinical Oncology ·Zida Compaoré Ida Carine, Ali Hosni, Shao Hui Huang, Tong Li, Wei Xu, Lin Lu, Andrew Bayley, Scott V. Bratman, John Cho, Meredith Giuliani, AMANDA VITÓRIA DE DEUS FERNANDES, Jolie Ringash, Riska Musfaiyah, Anna Spreafico, Jonathan C. Irish, Ralph Gilbert, Patrick Gullane, David P. Goldstein, Brian O’Sullivan, Andrew Hope	2021	8
14	Longitudinal health utility and symptom‐toxicity trajectories in patients with head and neck cancers Cancer ·Jianjun Ren, 昴中井, Katrina Hueniken, Ghazal Haddad, Andrew Hope, Shao Hui Huang, Anna Spreafico, Aaron R. Hansen, Bayardo Perez‐Ordoñez, David P. Goldstein, Scott V. Bratman, 進彦藤田, Yu Zhao, Wei Xu, John R. de Almeida, Geoffrey Liu	2021	9
15	Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma Radiotherapy and Oncology ·Ali Hosni, Shao Hui Huang, Wei Xu, Jie Su, Erin Watson, Michael Glogauer, Andrew Bayley, Scott V. Bratman, John Cho, Meredith Giuliani, Andrew Hope, John Kim, Brian O’Sullivan, Jolie Ringash, Anna Spreafico, David P. Goldstein, John Waldron, John R. de Almeida	2020	2
16	Characterization and outcomes of patients enrolled to multiple phase I cancer trials Cancer Chemotherapy and Pharmacology ·Fernando L. B. B. Oliveira, Lina Chen, Dennis J. Sepelak, Lisa Wang, Anna Spreafico, Aaron R. Hansen, Albiruni Ryan Abdul Razak, Philippe L. Bédard, Lillian L. Siu, Daniel Shepshelovich	2019	1
17	Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer Clinical Cancer Research ·Anna Spreafico, John J. Tentler, Todd M. Pitts, Aik Choon Tan, Mark A. Gregory, John J. Arcaroli, Luiz Filipe Oliveira Mansão, Martine C. McManus, Ryan J. Hansen, Jihye Kim, 張允瀞, Heather M. Selby, M. Afzal Hanid, T. Sherwood, Daniel L. Gustafson, James DeGregori, Wells A. Messersmith, Robert A. Winn, Sabine Eckhardt	2013	58
18	Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models Clinical Cancer Research ·Погодин Д. А., Todd M. Pitts, M. Afzal Hanid, Gillian N. Kulikowski, Aik Choon Tan, Martine C. McManus, Anna Spreafico, S Brusaferro, Heather M. Selby, John J. Tentler, Sabine Eckhardt, Stephen Leong	2013	46
19	Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib Clinical Cancer Research ·John J. Arcaroli, Kevin S. Quackenbush, ME Sweeney, Todd M. Pitts, Anna Spreafico, Marileila Varella‐Garcia, Lynne Bemis, Aik Choon Tan, M.T. Pérez, Basel M. Touban, Arvind Dasari, S. Gail Eckhardt, Wells A. Messersmith	2012	36
20	Identification of Predictive Markers of Response to the MEK1/2 Inhibitor Selumetinib (AZD6244) in K- ras –Mutated Colorectal Cancer Molecular Cancer Therapeutics ·John J. Tentler, Sujatha Nallapareddy, Aik Choon Tan, Anna Spreafico, Todd M. Pitts, Maria Pia Morelli, Heather M. Selby, S Brusaferro, Погодин Д. А., Gillian N. Kulikowski, Stephen Leong, John J. Arcaroli, Wells A. Messersmith, Sabine Eckhardt	2010	63

About Anna Spreafico

Anna Spreafico is a scholar working on Otorhinolaryngology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 229 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (65 papers), Lung Cancer Treatments and Mutations (39 papers), Cancer Genomics and Diagnostics (38 papers), Head and Neck Cancer Studies (38 papers), Colorectal Cancer Treatments and Studies (37 papers), CAR-T cell therapy research (25 papers), Melanoma and MAPK Pathways (20 papers) and Pancreatic and Hepatic Oncology Research (15 papers). The work is most often cited by research in Oncology (2.3k citations), Otorhinolaryngology (274 citations), Cancer Research (591 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Immunology (567 citations). Anna Spreafico has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Lillian L. Siu, Vanesa Gregorc, Aaron R. Hansen, Philippe L. Bédard, Bryan Coburn, Marc Oliva, Fred R. Hirsch, Giovanni Luca Ceresoli, Mauro Papotti and Lorinda Simms. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Radiotherapy and Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact